Transcat, Inc. distributes test and measurement instruments and provides accredited calibration services to a variety of industries including life sciences, pharmaceutical, petroleum refining, chemical manufacturing, public utility, pulp and paper, communications, automotive and aerospace.
Revenue (Most Recent Fiscal Year) | $278.42M |
Net Income (Most Recent Fiscal Year) | $14.52M |
PE Ratio (Current Year Earnings Estimate) | 41.97 |
PE Ratio (Trailing 12 Months) | 41.62 |
PEG Ratio (Long Term Growth Estimate) | -- |
Price to Sales Ratio (Trailing 12 Months) | 2.73 |
Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 2.69 |
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 19.80 |
Pre-Tax Margin (Trailing 12 Months) | 6.13% |
Net Margin (Trailing 12 Months) | 4.64% |
Return on Equity (Trailing 12 Months) | 6.66% |
Return on Assets (Trailing 12 Months) | 5.09% |
Current Ratio (Most Recent Fiscal Quarter) | 2.92 |
Quick Ratio (Most Recent Fiscal Quarter) | 2.36 |
Debt to Common Equity (Most Recent Fiscal Quarter) | 0.11 |
Inventory Turnover (Trailing 12 Months) | 13.06 |
Book Value per Share (Most Recent Fiscal Quarter) | $31.39 |
Earnings per Share (Most Recent Fiscal Quarter) | $0.59 |
Earnings per Share (Most Recent Fiscal Year) | $2.29 |
Diluted Earnings per Share (Trailing 12 Months) | $1.43 |
Exchange | NASDAQ |
Sector | Industrials |
Industry | Industrial Distribution |
Common Shares Outstanding | 9.32M |
Free Float | 9.06M |
Market Capitalization | $787.37M |
Average Volume (Last 20 Days) | 0.11M |
Beta (Past 60 Months) | 0.71 |
Percentage Held By Insiders (Latest Annual Proxy Report) | 2.80% |
Percentage Held By Institutions (Latest 13F Reports) | 98.34% |
Annual Dividend (Based on Last Quarter) | $0.00 |
Dividend Yield (Based on Last Quarter) | 0.00% |